Shuttle Pharmaceuticals shareholders approve merger proposals and company name change

Shuttle Pharmaceuticals shareholders approved share issuances potentially exceeding 17 million shares tied to its merger with United Dogecoin, alongside further issuances of up to roughly 5.0 million shares under an April 2026 securities purchase agreement. Investors also approved renaming the company United Compute Inc. and expanding the 2018 equity plan to 8.8 million authorized shares, creating material potential dilution. The acquired business is expanding Dogecoin/Litecoin mining through ElphaPex DG1+ units, with its first fleet targeted to begin operating within about 60 days using a site with renewable-energy access.

Analysis

SHPH is transitioning from a clinical-biotech valuation framework to a micro-cap crypto-mining financing vehicle, which typically produces a near-term promotional liquidity window but materially worsens per-share economics. The authorized conversion, warrant and equity-plan capacity creates a large overhang relative to the current public float; without a disclosed pro forma share count, ASIC purchase price, power rate, hosting terms and funding needs, no credible revenue or NAV per share can be calculated. The name change may attract AI/compute-oriented retail flow, but Dogecoin/Litecoin ASIC mining has no direct exposure to high-value AI compute economics, making the branding a potential source of eventual multiple compression rather than expansion.

The first operational milestone could support a days-to-60-day momentum trade if DOGE rallies and installed hashrate is independently verified, but mining economics are convex to DOGE/LTC prices, network difficulty and electricity uptime. A renewable-energy claim does not establish low delivered power cost: curtailment, interconnection, site hosting and maintenance costs determine whether equipment generates cash after depreciation. Over 6-18 months, recurring equity issuance is the dominant risk; a falling share price can force more shares or a reverse split to sustain Nasdaq compliance and fund fleet expansion.

The contrarian point is that the market may initially price this as scarce listed DOGE exposure, despite SHPH being a far weaker vehicle than liquid crypto proxies. Clean exposure through DOGE/USD or diversified miners offers better liquidity and less corporate-action risk; BTC miners such as CLSK, RIOT and MARA are not direct DOGE beneficiaries, though a broad crypto risk-on tape may temporarily lift them. The thesis is falsified if management discloses a low all-in power cost, fully funded expansion, limited near-term dilution, and independently audited production that supports positive operating cash flow at materially lower DOGE/LTC prices.

Key Decisions for Investors

• Avoid strategic long exposure to SHPH until management provides pro forma fully diluted shares, capex per DG1+ unit, all-in electricity/hosting cost, expected fleet hashrate and funding sources. Treat the absence of these disclosures before the stated installation window as a negative execution signal.
• For tactical books only, consider a small short SHPH into retail-driven spikes around the rebrand or claimed commissioning milestone, using a hard stop above the event-driven high and confirming borrow availability first. Target a 1-3 month normalization after conversion/warrant supply becomes tradeable; principal risks are low-float squeezes, reverse-split mechanics and a sharp DOGE rally.
• Set alerts for DOGE price, Litecoin/Dogecoin network difficulty, announced miner deliveries and any S-1/424B3 or resale-registration filing. A completed resale registration is a more actionable dilution catalyst than the shareholder vote itself.
• Do not use CLSK, RIOT or MARA as direct pairs against SHPH; their economics are primarily Bitcoin-linked. If hedging a speculative crypto-beta long in SHPH is unavoidable, use liquid DOGE exposure or a broad crypto proxy rather than BTC-miner equities.